Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drisapersen in Ambulant Boys with Duchenne Muscular Dystrophy
NCT01462292Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2011
- Primary completion
- May 2013
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of drisapersen in Duchenne muscular dystrophy (DMD), sponsored by GSK. Started Oct 2011; status: completed.
02
Drugs
drisapersen
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT01462292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01462292.